Clinical Utility of GST and CEA in Gastrointestinal Cancer

Abstract

Purpose: - To analyze the level of serum Glutathione-S-Transferase (GST) and Carcinoembryonic antigen (CEA) before and after different Cycles Of chemotherapy in GI carcinoma patients. Methods: - For the study comprising total 58 cases suffering from GI carcinoma stage I, stage II stage III and Stage IV (before and after different cycle of chemotherapy) were selected. All patients were clinically and histologically diagnosed. A total of 42 age and sex matched healthy subjects taken as control. The circulating levels of GST and CEA activity were assayed in the in the serum of control group and in patients with GI carcinoma. Results: - Serum level of GST and CEA were highly significant in GI carcinoma patients as compared to control group (p<0.001). After first cycle of chemotherapy (stage II) the activity of GST and CEA were significantly higher than before chemotherapy (stage I). In stage III (after second cycle of chemotherapy) activity was significantly decreased than that of stage II and the activity of GST and CEA was significantly decreased in stage IV (after third cycle of chemotherapy) than stage III (after second cycle of chemotherapy). Conclusion:- On the basis of data from our study, it can be stated that serum GST measurement in plasma may be useful tumor marker in gastrointestinal carcinoma, its activity might helpful to predict the response of chemotherapy in advance stage of cancer. CEA is a tumor marker that is measured using a blood test.CEA tumor marker is one of the general type tumor markers. A multiply increased CEA levels in the blood indicate to the presence of a malignant disease in the body, but not to the organ in which the malignant change has occurred. High levels of CEA may indicate that cancer has spread; however, other medical conditions and some treatments, including certain types of chemotherapy, may raise CEA levels. CEA tests are one way doctors can find out whether the cancer has spread or returned. Cancer that has spread or returned can be treated successfully for many patients. CEA measurement is mainly used to identify recurrences after surgical resection and for staging.

Authors and Affiliations

Ranjit S. Ambad, Rajesh Bhanudas Rajekar, Nishikant Ingole

Keywords

Related Articles

FORMULATION ANDEVALUATION OF TRANSDERMAL DRUG DELIVERY OF TORASEMIDE

A skin patch uses a special membrane to control the rate at which the liquid drug contained in the reservoir within the patch can pass through the skin and into the bloodstream. The basic components of any transdermal de...

A Comparative Study to Determine the Efficacy of Piracetam over Carbamazepine in the Treatment of Idiopathic Tinnitus

Tinnitus is a very common complaint faced by both medicine and ENT doctors alike which hampers the daily day to day activities of these patients. Many of them are idiopathic cases and there is still no complete cure with...

Multicentre Spectrum of Esophageal Motility Disorders in the Indian Subcontinent

Background - Motor disorders of the esophagus are rare and regional variations in their occurrence have not been studied in India. Aim and objectives - To study the spectrum of major and minor motor disorders in patient...

Pattern of Antimicrobial Utilization for Surgical Prophylaxis to Prevent Surgical Site Infection in Tertiary Care Teaching Hospital

Background: Surgical site infections (SSIs) are the second most common nosocomial infections and have adverse impact on patient. Despite proved effectiveness of surgical antimicrobial prophylaxis in reducing morbidity an...

ANALYSIS OF IMMUNOHISTOCHEMICAL EXPRESSION OF P16INK4a IN NEOPLASTIC SQUAMOUS CELL LESIONS OF CERVIX

Introduction: Cervical cancer is caused by persistent infection by high risk Human papilloma virus (HPV).Increasing expression of HPV viral oncogenes might be reflected by increased expression of p16. Hence immunohistoch...

Download PDF file
  • EP ID EP449381
  • DOI -
  • Views 69
  • Downloads 0

How To Cite

Ranjit S. Ambad, Rajesh Bhanudas Rajekar, Nishikant Ingole (2017). Clinical Utility of GST and CEA in Gastrointestinal Cancer. International Journal of Innovative Research in Medical Science, 2(7), 1001-1009. https://europub.co.uk/articles/-A-449381